Trial Profile
Myocardial infarction with ST-elevation treated by primary percutaneous intervention facilitated by early Reopro [abciximab] administration in Alsace
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2010
Price :
$35
*
At a glance
- Drugs Abciximab (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms MISTRAL
- 28 Aug 2010 Status changed from active, no longer recruiting to completed, based on an abstract presented at the Annual Congress of the European Society of Cardiology.
- 28 Aug 2010 Results presented in an abstract at the Annual Congress of the European Society of Cardiology.
- 28 Aug 2010 Primary endpoint 'Complete ST segment resolution' has not been met, according to an abstract presented at the Annual Congress of the European Society of Cardiology.